Mary F. Mulcahy

Research interests

Publications

• NCCN Guidelines® Insights: Rectal Cancer, Version 3.2024

  Journal of the National Comprehensive Cancer Network · 2024 · 10.6004/jnccn.2024.0041

• Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology

  Journal of the National Comprehensive Cancer Network · 2024 · 10.6004/jnccn.2024.0029

• Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology

  Journal of the National Comprehensive Cancer Network · 2023 · 10.6004/jnccn.2023.0019

• Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

  Journal of the National Comprehensive Cancer Network · 2022 · 10.6004/jnccn.2022.0051

• Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

  Journal of the National Comprehensive Cancer Network · 2022 · https://doi.org/10.6004/jnccn.2022.0008

• Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

  Journal of the National Comprehensive Cancer Network · 2021 · https://doi.org/10.6004/jnccn.2021.0012

• NCCN Guidelines Insights: Rectal Cancer, Version 6.2020

  Journal of the National Comprehensive Cancer Network · 2020 · 10.6004/jnccn.2020.0032

• Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

  The Lancet · 2020 · https://doi.org/10.1016/s0140-6736(20)31187-9

• Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

  Journal of the National Comprehensive Cancer Network · 2019 · https://doi.org/10.6004/jnccn.2019.0033

• Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology

  Journal of the National Comprehensive Cancer Network · 2018 · https://doi.org/10.6004/jnccn.2018.0061

• NCCN Guidelines Insights: Colon Cancer, Version 2.2018

  Journal of the National Comprehensive Cancer Network · 2018 · 10.6004/jnccn.2018.0021

• Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology

  Journal of the National Comprehensive Cancer Network · 2017 · 10.6004/jnccn.2017.0036

• Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000‐patient 15‐year experience

  Hepatology · 2017 · https://doi.org/10.1002/hep.29691

• Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma

  Gastroenterology · 2016 · https://doi.org/10.1053/j.gastro.2016.08.029

• Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology

  Journal of the National Comprehensive Cancer Network · 2016 · 10.6004/jnccn.2016.0137

• Esophageal and Esophagogastric Junction Cancers, Version 1.2015

  Journal of the National Comprehensive Cancer Network · 2015 · 10.6004/jnccn.2015.0028

• Unresectable Solitary Hepatocellular Carcinoma Not Amenable to Radiofrequency Ablation: Multicenter Radiology-Pathology Correlation and Survival of Radiation Segmentectomy

  Hepatology · 2014 · https://doi.org/10.1002/hep.27057

• Radiation lobectomy: Time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection

  Journal of Hepatology · 2013 · https://doi.org/10.1016/j.jhep.2013.06.015

• Gastric Cancer, Version 2.2013

  Journal of the National Comprehensive Cancer Network · 2013 · 10.6004/jnccn.2013.0070

• Increased Quality of Life Among Hepatocellular Carcinoma Patients Treated With Radioembolization, Compared With Chemoembolization

  Clinical Gastroenterology and Hepatology · 2013 · https://doi.org/10.1016/j.cgh.2013.04.028

• Expression of RORγt Marks a Pathogenic Regulatory T Cell Subset in Human Colon Cancer

  Science Translational Medicine · 2012 · https://doi.org/10.1126/scitranslmed.3004566

• Esophageal and Esophagogastric Junction Cancers

  Journal of the National Comprehensive Cancer Network · 2011 · 10.6004/jnccn.2011.0072

• Research Reporting Standards for Radioembolization of Hepatic Malignancies

  Journal of Vascular and Interventional Radiology · 2011 · https://doi.org/10.1016/j.jvir.2010.10.029

• Radiation Segmentectomy: A Novel Approach to Increase Safety and Efficacy of Radioembolization

  International Journal of Radiation Oncology*Biology*Physics · 2010 · https://doi.org/10.1016/j.ijrobp.2009.10.062

• Radioembolization Results in Longer Time-to-Progression and Reduced Toxicity Compared With Chemoembolization in Patients With Hepatocellular Carcinoma

  Gastroenterology · 2010 · https://doi.org/10.1053/j.gastro.2010.10.049

• Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)

  Journal of Clinical Oncology · 2010 · 10.1200/jco.2010.28.1386

• Radioembolization for Hepatocellular Carcinoma Using Yttrium-90 Microspheres: A Comprehensive Report of Long-term Outcomes

  Gastroenterology · 2009 · https://doi.org/10.1053/j.gastro.2009.09.006

• Alpha-Fetoprotein Response After Locoregional Therapy for Hepatocellular Carcinoma: Oncologic Marker of Radiologic Response, Progression, and Survival

  Journal of Clinical Oncology · 2009 · https://doi.org/10.1200/jco.2009.23.1282

• Complications Following Radioembolization with Yttrium-90 Microspheres: A Comprehensive Literature Review

  Journal of Vascular and Interventional Radiology · 2009 · https://doi.org/10.1016/j.jvir.2009.05.030

• A Comparative Analysis of Transarterial Downstaging for Hepatocellular Carcinoma: Chemoembolization Versus Radioembolization

  American Journal of Transplantation · 2009 · https://doi.org/10.1111/j.1600-6143.2009.02695.x

• Radiation Lobectomy: Preliminary Findings of Hepatic Volumetric Response to Lobar Yttrium-90 Radioembolization

  Annals of Surgical Oncology · 2009 · https://doi.org/10.1245/s10434-009-0454-0

• Radiologic–pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres #

  Hepatology · 2008 · https://doi.org/10.1002/hep.22747

• Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis

  Hepatology · 2007 · https://doi.org/10.1002/hep.21980

• Treatment of Unresectable Primary and Metastatic Liver Cancer with Yttrium-90 Microspheres (TheraSphere®): Assessment of Hepatic Arterial Embolization

  CardioVascular and Interventional Radiology · 2006 · https://doi.org/10.1007/s00270-005-0171-4

• Yttrium-90 microspheres (TheraSphere®) treatment of unresectable hepatocellular carcinoma: Downstaging to resection, RFA and bridge to transplantation

  Journal of Surgical Oncology · 2006 · https://doi.org/10.1002/jso.20609

Current projects

No projects listed.